Dexrazoxane is hydrolyzed to an active metabolite that chelates intracellular iron that is believed to prevent the formation of an anthracycline-iron complex thought to be the primary cause of anthracycline-induced cardiomyopathy.
Dextran 70 is a relatively low cost colloid for the adjunctive treatment of hypovolemic shock. Hetastarch is the more commonly employed synthetic colloid used today.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
現行 standard 劑量是歷史人體 1000／1000／500 mg/m² 外滲方案誤映射。犬合併治療與外滲資料方案異質，貓證據極少；人用、犬研究、病例方案不可互換。只有院內腫瘤／急診危害性藥物流程可個案決定。
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。